Logo for OncoCyte Corporation

OncoCyte Investor Relations Material

Latest events

Logo for OncoCyte Corporation

Q3 2023

OncoCyte
Logo for OncoCyte

Q3 2023

9 Nov, 2023
Logo for OncoCyte

Q2 2023

10 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. Its tests apply genetic analysis technology to advance early detection of cancer. The company's lead product candidates are Circulating Tumor Cell (CTC), a blood test to detect lung cancer; and DetermaIO, a bioinformatic analysis software that provides interpretative information on the outputs from various types of assays, including CTC. It is also developing DetermaVu, a cell free DNA blood test for detecting various types of lung cancer; DetermaSolver, a proprietary technology.